Cipla | CIPLA - Current Assets


Cipla reported INR241.47B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Arca Biopharma USD 884.56M 489.31M Jun/2026
aTyr Pharma USD 58.36M 9.21M Jun/2026
Bio Path USD 677K 14K Mar/2026
Brainstorm Cell Therapeutics USD 316K 132K Jun/2026
Capricor Therapeutics USD 242.13M 40.96M Jun/2026
Cara Therapeutics USD 25.33M 6.21M Mar/2026
Cipla INR 241.47B 7.71B Mar/2026
Dr.Reddys Laboratories INR 297.32B 2.01B Sep/2026
Immunic USD 188.76M 165.89M Mar/2026
Minerva Neurosciences USD 83.1M 70.08M Dec/2025
Nektar Therapeutics USD 589.04M 322.77M Mar/2026
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
Sun Pharmaceuticals INR 638.6B 37.24B Mar/2026
TherapeuticsMD USD 11.82M 303K Jun/2024
UPL INR 422.95B 9.97B Mar/2026